{"pmid":32367861,"title":"Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test.","text":["Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test.","Lung India","Joob, Beuy","Wiwanitkit, Viroj","32367861"],"journal":"Lung India","authors":["Joob, Beuy","Wiwanitkit, Viroj"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32367861","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.4103/lungindia.lungindia_126_20","topics":["Diagnosis"],"weight":1,"_version_":1666138496230752256,"score":9.490897,"similar":[{"pmid":32369202,"title":"Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR.","text":["Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR.","Until an effective vaccine is available, interruption of community circulation of SARS- CoV-2 is crucial to control virus spread. To this end, systematic testing of large population groups by RT-PCR is mandatory to case identification and contact tracing thereby minimizing the likelihood of resurgence in contagion.(1) This article is protected by copyright. All rights reserved.","J Med Virol","Torres, Ignacio","Albert, Eliseo","Navarro, David","32369202"],"abstract":["Until an effective vaccine is available, interruption of community circulation of SARS- CoV-2 is crucial to control virus spread. To this end, systematic testing of large population groups by RT-PCR is mandatory to case identification and contact tracing thereby minimizing the likelihood of resurgence in contagion.(1) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Torres, Ignacio","Albert, Eliseo","Navarro, David"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369202","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/jmv.25971","topics":["Diagnosis"],"weight":1,"_version_":1666138496259063809,"score":67.513695},{"pmid":32401374,"title":"Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.","text":["Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.","Coronavirus disease 2019 (COVID-19) is a rapidly escalating pandemic that has spread to many parts of the world. Current data available on COVID-19 would suggest that SARS-CoV-2 virus is shed through the gastrointestinal system via feces. Some reports further indicate that a subset of COVID-19 patients may continue to have positive SARS-CoV-2 anal/rectal swab and stool test after negative conversion of nasopharyngeal test. This paper analyses current literature to so as to shed some light on this issue. This article is protected by copyright. All rights reserved.","J Med Virol","Kipkorir, Vincent","Cheruiyot, Isaac","Ngure, Brian","Misiani, Musa","Munguti, Jeremiah","32401374"],"abstract":["Coronavirus disease 2019 (COVID-19) is a rapidly escalating pandemic that has spread to many parts of the world. Current data available on COVID-19 would suggest that SARS-CoV-2 virus is shed through the gastrointestinal system via feces. Some reports further indicate that a subset of COVID-19 patients may continue to have positive SARS-CoV-2 anal/rectal swab and stool test after negative conversion of nasopharyngeal test. This paper analyses current literature to so as to shed some light on this issue. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Kipkorir, Vincent","Cheruiyot, Isaac","Ngure, Brian","Misiani, Musa","Munguti, Jeremiah"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401374","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/jmv.26007","keywords":["covid-19","coronavirus","prolonged sars-cov-2 detection"],"topics":["Diagnosis"],"weight":1,"_version_":1666865855041896449,"score":62.440075},{"pmid":32401343,"title":"Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.","text":["Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.","In the age of a pandemic, such as the ongoing one caused by SARS-CoV-2, the world faces a limited supply of tests, personal protective equipment, and factories and supply chains are struggling to meet the growing demands. This study aimed to evaluate the efficacy of specimen pooling for testing of SARS-CoV-2 virus, to determine whether costs and resource savings could be achieved without impacting the sensitivity of the testing. Ten previously tested nasopharyngeal and throat swab specimens by real-time PCR, were pooled for testing, containing either one or two known positive specimens of varying viral concentrations. Specimen pooling did not affect the sensitivity of detecting SARS-CoV-2 when the PCR cycle threshold (Ct) of original specimen was lower than 35. In specimens with low viral load (Ct>35), 2 out of 15 pools (13.3%) were false negative. Pooling specimens to test for COVID-19 infection in low prevalence (</=1%) areas or in low risk populations can dramatically decrease the resource burden on laboratory operations by up to 80%. This paves the way for large-scale population screening, allowing for assured policy decisions by governmental bodies to ease lockdown restrictions in areas with a low incidence of infection, or with lower risk populations. This article is protected by copyright. All rights reserved.","J Med Virol","Wacharapluesadee, Supaporn","Kaewpom, Thongchai","Ampoot, Weenassarin","Ghai, Siriporn","Khamhang, Worrawat","Worachotsueptrakun, Kanthita","Wanthong, Phanni","Nopvichai, Chatchai","Supharatpariyakorn, Thirawat","Putcharoen, Opass","Paitoonpong, Leilani","Suwanpimolkul, Gompol","Jantarabenjakul, Watsamon","Hemachudha, Pasin","Krichphiphat, Artit","Buathong, Rome","Plipat, Tanarak","Hemachudha, Thiravat","32401343"],"abstract":["In the age of a pandemic, such as the ongoing one caused by SARS-CoV-2, the world faces a limited supply of tests, personal protective equipment, and factories and supply chains are struggling to meet the growing demands. This study aimed to evaluate the efficacy of specimen pooling for testing of SARS-CoV-2 virus, to determine whether costs and resource savings could be achieved without impacting the sensitivity of the testing. Ten previously tested nasopharyngeal and throat swab specimens by real-time PCR, were pooled for testing, containing either one or two known positive specimens of varying viral concentrations. Specimen pooling did not affect the sensitivity of detecting SARS-CoV-2 when the PCR cycle threshold (Ct) of original specimen was lower than 35. In specimens with low viral load (Ct>35), 2 out of 15 pools (13.3%) were false negative. Pooling specimens to test for COVID-19 infection in low prevalence (</=1%) areas or in low risk populations can dramatically decrease the resource burden on laboratory operations by up to 80%. This paves the way for large-scale population screening, allowing for assured policy decisions by governmental bodies to ease lockdown restrictions in areas with a low incidence of infection, or with lower risk populations. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Wacharapluesadee, Supaporn","Kaewpom, Thongchai","Ampoot, Weenassarin","Ghai, Siriporn","Khamhang, Worrawat","Worachotsueptrakun, Kanthita","Wanthong, Phanni","Nopvichai, Chatchai","Supharatpariyakorn, Thirawat","Putcharoen, Opass","Paitoonpong, Leilani","Suwanpimolkul, Gompol","Jantarabenjakul, Watsamon","Hemachudha, Pasin","Krichphiphat, Artit","Buathong, Rome","Plipat, Tanarak","Hemachudha, Thiravat"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401343","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/jmv.26005","keywords":["covid-19","pcr","sars-cov-2","cost efficiency","real-time pcr","specimen pooling"],"topics":["Diagnosis"],"weight":1,"_version_":1666714494869438464,"score":55.17089},{"pmid":32315809,"pmcid":"PMC7166099","title":"Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.","text":["Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.","BACKGROUND: Since the outbreak of coronavirus disease (COVID-19) in Wuhan in December 2019, by March 10, 2020, a total of 80,932 confirmed cases have been reported in China. Two consecutively negative RT-PCR test results in respiratory tract specimens is required for the evaluation of discharge from hospital, and oropharyngeal swabs were the most common sample. However, false negative results occurred in the late stage of hospitalization, and avoiding false negative result is critical essential. METHODS: We reviewed the medical record of 353 patients who received tests with both specimens simultaneously, and compared the performance between nasopharyngeal and oropharyngeal swabs. RESULTS: Of the 353 patients (outpatients, 192; inpatients, 161) studied, the median age was 54 years, and 177 (50.1%) were women. Higher positive rate (positive tests/total tests) was observed in nasopharyngeal swabs than oropharyngeal swabs, especially in inpatients. Nasopharyngeal swabs from inpatients showed higher positive rate than outpatients. Nasopharyngeal swabs from male showed higher positive rate than female, especially in outpatients. Detection with both specimens slightly increased the positive rate than nasopharyngeal swab only. Moreover, the consistency between from nasopharyngeal and oropharyngeal swabs were poor (Kappa=0.308). CONCLUSION: In conclusion, our study suggests that nasopharyngeal swabs may be more suitable than oropharyngeal swab at this stage of COVID-19 outbreak.","Int J Infect Dis","Wang, Xiong","Tan, Li","Wang, Xu","Liu, Weiyong","Lu, Yanjun","Cheng, Liming","Sun, Ziyong","32315809"],"abstract":["BACKGROUND: Since the outbreak of coronavirus disease (COVID-19) in Wuhan in December 2019, by March 10, 2020, a total of 80,932 confirmed cases have been reported in China. Two consecutively negative RT-PCR test results in respiratory tract specimens is required for the evaluation of discharge from hospital, and oropharyngeal swabs were the most common sample. However, false negative results occurred in the late stage of hospitalization, and avoiding false negative result is critical essential. METHODS: We reviewed the medical record of 353 patients who received tests with both specimens simultaneously, and compared the performance between nasopharyngeal and oropharyngeal swabs. RESULTS: Of the 353 patients (outpatients, 192; inpatients, 161) studied, the median age was 54 years, and 177 (50.1%) were women. Higher positive rate (positive tests/total tests) was observed in nasopharyngeal swabs than oropharyngeal swabs, especially in inpatients. Nasopharyngeal swabs from inpatients showed higher positive rate than outpatients. Nasopharyngeal swabs from male showed higher positive rate than female, especially in outpatients. Detection with both specimens slightly increased the positive rate than nasopharyngeal swab only. Moreover, the consistency between from nasopharyngeal and oropharyngeal swabs were poor (Kappa=0.308). CONCLUSION: In conclusion, our study suggests that nasopharyngeal swabs may be more suitable than oropharyngeal swab at this stage of COVID-19 outbreak."],"journal":"Int J Infect Dis","authors":["Wang, Xiong","Tan, Li","Wang, Xu","Liu, Weiyong","Lu, Yanjun","Cheng, Liming","Sun, Ziyong"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315809","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ijid.2020.04.023","keywords":["2019-ncov","covid-19","rt-pcr","sars-cov-2"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493517037569,"score":54.08406},{"pmid":32341143,"title":"Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.","text":["Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (Modified CDC), the Simplexa COVID-19 Direct (Diasorin Molecular), GenMark ePlex SARS-CoV-2 assay (GenMark) and the Hologic Panther Fusion(R) SARS-CoV-2 assay (Hologic). This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.","J Clin Microbiol","Zhen, Wei","Manji, Ryhana","Smith, Elizabeth","Berry, Gregory J","32341143"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (Modified CDC), the Simplexa COVID-19 Direct (Diasorin Molecular), GenMark ePlex SARS-CoV-2 assay (GenMark) and the Hologic Panther Fusion(R) SARS-CoV-2 assay (Hologic). This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made."],"journal":"J Clin Microbiol","authors":["Zhen, Wei","Manji, Ryhana","Smith, Elizabeth","Berry, Gregory J"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341143","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1128/JCM.00743-20","locations":["Wuhan","Hubei","China","New York"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495765184515,"score":52.380974}]}